Treatment (Immunotherapy) Veterinary Evidence-Based

Allergy Shots for Dogs: Allergen-Specific Immunotherapy (ASIT) & Cytopoint

When pet parents hear 'allergy shots for dogs', they are usually referring to one of two distinct treatments: Allergen-Specific Immunotherapy (ASIT)—a custom desensitization vaccine formulated from allergy testing—or Cytopoint (Lokivetmab), an innovative monoclonal antibody injection that neutralizes the itch signal for 4 to 8 weeks. Understanding the difference between desensitization and temporary neutralization is vital for long-term management.

65 - 75%
ASIT Success Rate
of dogs achieve significant clinical improvement
6 - 12 Months
ASIT Timeline
Requires months to retrain the immune system
4 - 8 Weeks
Cytopoint Duration
Fast temporary relief without retraining immunity

Comparing ASIT Desensitization Shots vs Cytopoint Injections

FeatureASIT (Allergy Desensitization Shots)Cytopoint (Monoclonal Antibody Injection)
MechanismGradual exposure to microscopic doses of offending allergens to induce immune toleranceMimics natural antibodies to bind and neutralize the IL-31 itch cytokine
Testing Required?Yes (Requires intradermal skin testing or serum IgE testing)No (Can be given based on clinical symptoms without prior testing)
Onset of ActionSlow: takes 3 to 12 months to see full benefitFast: itch relief begins within 24 hours
AdministrationInjections at home (or sublingual oral drops) on a tapering scheduleAdministered at the veterinary clinic every 4 to 8 weeks as needed
Long-Term GoalPotentially reduce or eliminate lifelong reliance on daily drugsConvenient ongoing itch suppression

Frequently Asked Questions

How much do allergy shots for dogs cost?
Initial testing (IDST or blood panel) typically costs $300 to $600. A custom ASIT vial lasting 5-7 months ranges from $200 to $400. In comparison, Cytopoint injections cost between $70 and $160 per visit depending on your dog's body weight.
Related Canine Allergy Decision Pillars
Allergy Topic Hub

Central portal linking all 5 clusters and testing methodologies.

Topic Hub

Evidence-Based Veterinary References

  1. Cosgrove, S. B., Wren, J. A., Cleaver, D. M., et al. (2013). Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis. Veterinary Dermatology, 24(5), 479-e114. [View Reference]
  2. Moyaert, H., Van Brussel, L., Borowski, S., et al. (2017). A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to cyclosporine in dogs with atopic dermatitis. Veterinary Dermatology, 28(6), 593-e145. [View Reference]
  3. Merck Veterinary Manual. (2024). Allergies in Dogs. Merck Sharp & Dohme Corp. [View Reference]
  4. Today's Veterinary Practice. (2023). Canine Atopic Dermatitis Updates: Diagnosis & Treatment. NAVC Publications. [View Reference]